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Typing for HLA-A and -B antigens was performed on 87 children with definite 
juvenile dermatomyositis (JDMS). A significantly increased frequency of HLA-B8 
(estimated relative risk = 2.8, P, < 0.01) was observed among White patients, but 
not among Blacks or Latin Americans with JDMS. No abnormality of HLA hap- 
lotype segregation was observed among 38 healthy siblings of the JDMS probands. 
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Juvenile dermatomyositis (JDMS) is a chronic 
inflammatory disease of unknown etiology 
which is characterized by a typical rash and 
symmetrical proximal myopathy with onset in 
childhood. We have previously reported a 
greater than expected frequency of HLA-B8 
among 16 White patients with JDMS 
(Pachman et al. 1977). In order to confirm 
this finding and to investigate its relationship 
to the pathogenesis of this rare disease, we 
undertook a multicenter collaborative inves- 
tigation of immunogenetic factors in JDMS. 
Material and methods 
Juvenile derrnatomyositis subjects. A total of 
100 patients with JDMS were ascertained 
from the records of Pediatric Rheumatology 
Clinics at Children’s Memorial Hospital 
(Chicago), University of Michigan Hospital 
(Ann Arbor), Los Angeles Children’s Hospi- 
tal, Texas Scottish Rite Hospital (Dallas), and 
Children’s Hospital Medical Center (Cincin- 
nati). Ninety of these patients, including 11 of 
our original series of 16 (Pachman et al. 
1977), were considered to  have definite 
JDMS according to the strict criteria of Bohan 
& Peter (1975). Each patient exhibited the 
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typical rash and three or four of the following 
additional features: symmetrical limb-girdle 
muscle weakness, histological evidence of 
myositis on muscle biopsy, elevated serum 
concentration of skeletal muscle enzymes and 
characteristic electromyographic abnor- 
malities. The age at onset of disease in these 
patients ranged from 1-21 years, with a mean 
of 8.0 years. There were 28 males and 62 
females. Sixty-seven of the patients were 
White, 11 were Black, 9 were Latin Ameri- 
cans, 1 was Oriental and 2 were of mixed ra- 
cial origin. These last three patients were 
excluded from the present analysis. Of the 87 
patients included in this study, 23 were from 
Chicago, 17 from Ann Arbor, 20 from Los 
Angeles, 10 from Dallas, and 17 from Cincin- 
nati. 
Family studies. The families of 15 of the 
Chicago patients were extensively studied. 
Detailed family histories were obtained with 
particular attention being paid to im- 
munological and putative autoimmune dis- 
eases. Blood for HLA typing was requested 
from all parents and siblings of the probands. 
A total of 30 parents, 44 full siblings, and 2 
half-siblings were tested. None had any his- 
tory suggestive of JDMS or polymyositis. 
HLA antigen frequency controls. Normal 
population frequencies of the HLA-A and -B 
antigens among healthy Whites, Blacks and 
Latin Americans were obtained from the joint 
report of the Eighth International Workshop 
on Histocompatibility (Baur & Danilovs 
1980). Population groups 11 (United States 
Caucasians), 2 (American Negroes) and 9 
(Mexicans) were used. 
HLA typing and data analysis. Typing for 
HLA-A and HLA-B antigens on all patients 
and family members was performed by the 
standard NIH 2-stage lymphocyte micro- 
toxicity test using NIH plates (National In- 
stitute of Arthritis and Infectious Diseases 
1976) in the laboratory of Dr. Olga Jonasson. 
The study was performed over a 5-year period 
during which the number of available typing 
sera increased and splits of several antigens 
occurred. To permit consistent analysis, all 
patients positive for antigens which had been 
split during the study were considered to be 
positive for the unsplit antigen. All patients 
were tested for at least 10 HLA-A antigens 
and at least 17 HLA-B antigens. 
HLA antigen frequencies were compared in 
patients and controls of similar ethnic origin 
by Fisher’s exact test. Two-tailed probabilities 
of less than 0.05 after multiplication by 27 to 
correct for the number of antigens tested were 
considered significant (Grumet et al. 1971). 
Relative risks were estimated by Woolf s 
method (Woolf 1955) and segregation 
analysis was performed using the X2 test for 
goodness of fit. 
Results 
H L A  typing. HLA-A and -B antigens were 
determined in 87 White, Black, or Latin 
American patients with definite JDMS. Table 
1 compares the antigen frequencies found in 
these patients with the frequencies in healthy 
controls of similar ethnic origin. HLA-B8 
occurred significantly more often among 
White JDMS patients than among controls. 
This association is not apparent among Black 
or Latin American patients. The estimated 
relative risk of JDMS among Whites with 
HLA-B8 is 2.8 with a 95% confidence inter- 
val of 1.6 to 4.8. An interesting observation is 
that the estimated relative risk for JDMS 
among Whites with HLA-B7 is only 0.2 (95% 
confidence interval = 0.06 to 0.65); this as- 
sociation is statistically significant before 
correction was made for the number of an- 
tigens tested (P = 0.003), but not after (P, = 
0.081). 
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Table 1. 
HLA antigen frequences in patients with juvenile dermatomyositis and in healthy controls. 
HLA antigens’ White Black Latin American 
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+ Splits indicated in parentheses - see Methods. 
** P, < 0.01. 
HLA family studies. HLA typing was per- 
formed on the parents and all available nor- 
ma1 siblings of 15 JDMS patients. Twelve of 
the families were informative regarding seg- 
regation of HLA haplotypes from both par- 
ents. Segregation of HLA haplotypes was 
normal in unaffected siblings of JDMS pa- 
tients (Table 2). Seventeen siblings inherited 
the proband’s haplotype from the father; 21 
siblings inherited the other haplotype (Xz = 
0.42). Twenty siblings inherited the proband’s 
haplotype from the mother; 17 did not (Xz = 
0.24). 
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Table 2 .  
Distribution of H L A  haplotypes in 37 normal sib- 
lings of patients with juvenile dermatomyositis. * 
Haplotypes’ 
alc ald hlc bld 
Expected 25% 25% 25% 25% 
Observed 27% 16% 27% 30% 
* One sibling who exhibited a maternal recombin- 
ant HLA-B/DR haplotype is excluded from the 
table. 
+ The haplotype transmitted to the proband from 
the father is arbitrarily designated “a”, and the 
haplotype transmitted to the proband from the 
mother, “c”. The other paternal and maternal 
haplotypes are designated “b” and “d”, respec- 
tively. Thus, a/c siblings have both haplotypes in 
common with the proband, aid siblings share just 
the paternal haplotype with the proband, b/c 
siblings share just the maternal haplotype with 
the proband, and bid siblings differ from the 
proband at both haplotypes. 
Discussion 
Juvenile dermatomyositis is an uncommon 
disease. In spite of having identified patients 
from five large pediatric rheumatology clinics, 
we were able to obtain only 90 who were ap- 
propriate for this study. HLA antigen fre- 
quencies are known to differ between races, 
so the probands had to be divided into racial 
groups for analysis. Consequently, the 
number of patients studied in each group was 
relatively small, and biologically important 
associations between JDMS and certain HLA 
types may have been missed, especially among 
Blacks and Latin Americans. 
Any demonstration of a population as- 
sociation between a disease and genetic mar- 
kers such as HLA antigens depends critically 
on selection of an appropriate control group. 
In addition to being of the same ethnic origin 
as the patients, the controls ideally should be 
tested in the same laboratory as the patients 
with the same reagents at the same time. Be- 
cause of the time required to amass the study 
group and because these patients were drawn 
from five different large referral areas, no 
ideal control groups were available to us. We 
therefore used as controls normal Americans 
of similar ethnic origin who had been typed by 
the same techniques during the Eighth Inter- 
national Histocompatibility Workshop. This 
approach is probably satisfactory for HLA-A 
and -B typing, which is well standardized. 
The data presented here substantiate the 
association between JDMS and HLA-B8 in 
Whites which we previously reported in a 
much smaller group of patients (Pachman et 
al. 1977). A similar association between 
HLA-B8 and polymyositis in White adults has 
been found by some workers (Behan et al. 
1978, Hirsch et al. 1981) but not others 
(Cumming et al. 1977). However, these data 
are not strictly comparable to ours because 
adult polymyositis and JDMS are probably 
different diseases (Bohan & Peter 1975). In 
fact, JDMS itself is sometimes difficult to 
diagnose clinically and may well be etiologi- 
cally heterogeneous. In order to circumvent 
this problem as much as possible, we insisted 
that the patients included in our study have 
definite JDMS according to the strict criteria 
of Bohan & Peter (1975). 
The data reported here place JDMS into 
company with other HLA-B8 associated dis- 
eases including dermatitis herpetiformis, 
celiac disease, myasthenia gravis, Sjogren 
syndrome, idiopathic Addison disease, insu- 
lin-dependent diabetes mellitus, and Graves 
disease (Nerup et al. 1977, Friedman & Fial- 
kow 1978). All of these conditions are of un- 
known but probably complex etiology and all 
exhibit autoimmune manifestations. This 
raises the possibility that JDMS may also be 
an “autoimmune disease.” Autoimmunity is 
being studied in this series of patients, and the 
results of these investigations will be reported 
in the near future. 
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